ZALCITABINE

Zalcitabine is an NRTI antiviral inhibiting HIV reverse transcriptase. Side effects include peripheral neuropathy, pancreatitis, mouth ulcers, and rare hematologic toxicity. Only GMP materials will be supplied, logistics all according to GDP.

SKU: f1314e3b8d4f Category: Tag:

Product Description


Mechanism of Action

ZALCITABINE demonstrates a multiaxis biochemical interference profile spanning catalyticdomain perturbation, mitochondrialnetwork recalibration, ionflux redistribution, membranepotential modulation, cytoskeletal remodelling, redoxequilibrium restructuring and transcriptionfactor pathway reprogramming. Its molecular architecture supports docking to catalytic residues, allosteric control nodes, transmembrane helices, nucleotidebinding sites, redoxbuffer matrices and polymeric scaffold proteins. This enables systemwide modulation across metabolic, structural, genomic and electrophysiological regulatory layers.

Mechanistic effects include redistribution of phosphorylation flux across ERK/MAPK/JNK/p38 signalling axes, modulation of PI3KAKT survivalpathway geometry, reconfiguration of Gprotein coupling logic, reshaping of Ca²⁺ microdomain behaviour, alteration of IP/DAG cascade topology and amplitude recalibration within the cAMPPKA axis. Mitochondrial influences include ETCcomplex rebalancing, ATP/ADP flux modelling shifts, ROSthreshold displacement, mitochondrialmembrane potential polarity adjustments and crossorganelle stresssignal propagation between ER and mitochondrial systems.

Advanced

  • Kinomelevel catalyticcascade interference mapping
  • Highprecision ligand docking & conformationaltransition simulations
  • UPR/ERstress, mitophagy & autophagicflux network modelling
  • Multiomics integration (RNAseq, proteomics, metabolomics, phosphoproteomics)
  • Cytoskeletal mechanics, forcedistribution profiling & polymer turnover
  • Cellfate modelling across apoptosis, necroptosis, ferroptosis & parthanatos
  • SAR/QSAR optimisation with machinelearningbased compound performance modelling

Toxicodynamics & Hazard Spectrum

  • Rapid ROS accumulation & antioxidantbuffer collapse
  • Mitochondrial fragmentation or ETC suppression
  • Severe Na⁺/K⁺/Ca²⁺ ionflux destabilisation
  • Cytoskeletal depolymerisation & membrane-integrity failure
  • Hyperactivation of NF-κB, STAT & IRF inflammatory regulators
  • Induction of multiaxis programmed-cell-death pathways
  • Epigenetic drift including methylation/acetylation instability

For expert laboratory research only not intended for biological use.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C9H13N3O3

Molecular Weight

211.22 g/mol

CAS Number

7481-89-2

Storage Condition

PRECAUTIONS FOR "CARCINOGENS": Storage site should be as close as practical to lab in which carcinogens are to be used, so that only small quantities required for … expt need to be carried. Carcinogens should be kept in only one section of cupboard, an explosion-proof refrigerator or freezer (depending on chemicophysical properties …) that bears appropriate label. An inventory … should be kept, showing quantity of carcinogen & date it was acquired … Facilities for dispensing … should be contiguous to storage area. /Chemical Carcinogens/

Solubility

50 to 100 mg/mL at 66 °F (NTP, 1992)

Purity

Purity information is available upon request (COA).

Synonym

zalcitabine; Dideoxycytidine; 7481-89-2; 2',3'-DIDEOXYCYTIDINE; ddCyd

IUPAC/Chemical Name

4-amino-1-[(2R,5S)-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one

InChl Key

WREGKURFCTUGRC-POYBYMJQSA-N

InChl Code

InChI=1S/C9H13N3O3/c10-7-3-4-12(9(14)11-7)8-2-1-6(5-13)15-8/h3-4,6,8,13H,1-2,5H2,(H2,10,11,14)/t6-,8+/m0/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/24066;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download